MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.

CONCLUSION: MiR-34a may enhance the inhibitory effect of doxorubicin by downregulating MDR1/P-gp and AXL, which may be related to p53 expression.
PMID: 31235998 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - June 13, 2019 Category: Gastroenterology Authors: Zheng SZ, Sun P, Wang JP, Liu Y, Gong W, Liu J Tags: World J Gastroenterol Source Type: research